Robotic thoracic surgery for non-small cell lung cancer: initial experience in Brazil
| Autor: | Rui Haddad, Carlos Eduardo Teixeira-Lima, Felipe Carvalho Braga Dos Santos, Paulo Manuel Pêgo-Fernandes, Benoit Jacques Bibas, Pedro Henrique Xavier Nabuco-de-Araujo, Ricardo Mingarini Terra, Leticia Leone Lauricella, José Ribas Milanez-de-Campos |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty RC705-779 business.industry Mortality rate Retrospective cohort study 030204 cardiovascular system & hematology medicine.disease Lung neoplasms/surgery Surgery Lung neoplasms/mortality 03 medical and health sciences Diseases of the respiratory system 0302 clinical medicine 030228 respiratory system Epidermoid carcinoma Interquartile range Cardiothoracic surgery Carcinoma Medicine Robotic surgery Robotic surgical procedures business Lung cancer |
| Zdroj: | Jornal Brasileiro de Pneumologia v.46 n.1 2020 Jornal Brasileiro de Pneumologia Sociedade Brasileira de Pneumologia e Tisiologia (SBPT) instacron:SBPT |
| Popis: | Objective: To describe the morbidity, mortality, and rate of complete resection associated with robotic surgery for the treatment of non-small cell lung cancer in Brazil, as well as to report the rates of overall survival and disease-free survival in patients so treated. Methods: This was a retrospective study of patients diagnosed with non-small cell lung carcinoma and undergoing resection by robotic surgery at one of six hospitals in Brazil between February of 2015 and July of 2018. Data were collected retrospectively from the electronic medical records. Results: A total of 154 patients were included. The mean age was 65 ± 9.5 years (range, 30-85 years). The main histological diagnosis was adenocarcinoma, which was identified in 128 patients (81.5%), followed by epidermoid carcinoma, identified in 14 (9.0%). Lobectomy was performed in 133 patients (86.3%), and segmentectomy was performed in 21 (13.7%). The mean operative time was 209 ± 80 min. Postoperative complications occurred in 32 patients (20.4%). The main complication was air leak, which occurred in 15 patients (9.5%). The median (interquartile range) values for hospital stay and drainage time were 4 days (3-6 days) and 2 days (2-4 days), respectively. There was one death in the immediate postoperative period (30-day mortality rate, 0.5%). The mean follow-up period was 326 ± 274 days (range, 3-1,110 days). Complete resection was achieved in 97.4% of the cases. Overall mortality was 1.5% (3 deaths), and overall survival was 97.5%. Conclusions: Robotic pulmonary resection proved to be a safe treatment for lung cancer. Longer follow-up periods are required in order to assess long-term survival. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|